8th June 2018

Cycling Athlete Roger Ainslie Accepts Sanction for ADRV

USADA announced today that Roger Ainslie, of Fallbrook, Calif., an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a four-year sanction for his violation. This sanction was subsequently reduced by six-months at the discretion of USADA and the World Anti-Doping Agency (WADA), and in accordance with the rules, based on Ainslie’s prompt admission of the violation.

Ainslie, 26, tested positive for GW1516 sulfone following an in-competition urine sample he provided at the USA Cycling Elite & Jr. Track National Championships on August 3, 2017. GW1516 sulfone, a metabolite of GW1516, is a Peroxisome Proliferator Activated Receptor δ (PPARδ) agonist and is categorized as a non-Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Cycling Union Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the WADA Prohibited List.

GW1516, also known as GW501516, is an experimental drug that was terminated by the pharmaceutical company after serious toxicities occurred during pre-clinical studies. In 2013, WADA issued an alert warning that GW1516, which is not approved by the FDA, is being sold illegally on the black market and obtained by athletes.

Ainslie’s 42-month period of ineligibility began on August 3, 2017, the date his positive sample was collected. In addition, Ainslie has been disqualified from all competitive results obtained on and subsequent to August 3, 2017, including forfeiture of any medals, points and prizes.

• This media release was published by the US Anti-Doping Agency (USADA) on 8 June 2018. Click here for the original.

You may also like...

Pin It on Pinterest

Share This